How many Forteo (teriparatide) pens are needed for a 3-month supply?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Forteo (Teriparatide) Supply for 3 Months

For a 3-month supply of Forteo (teriparatide), 3 pens are needed as each pen contains a 28-day supply.

Dosage and Administration Details

Teriparatide (Forteo) is administered as a once-daily subcutaneous injection of 20 mcg into the thigh or abdominal region 1. Each pen is designed for specific duration of use:

  • Each Forteo pen contains 620 mcg/2.48 mL (250 mcg/mL) of teriparatide solution 1
  • Each pen delivers exactly 28 daily doses of 20 mcg 2
  • For a 3-month period (approximately 90-92 days), 3 complete pens are required

Calculation Breakdown

  1. Daily dose: 20 mcg per day
  2. Each pen contains: 28 daily doses
  3. Number of days in 3 months: approximately 90-92 days
  4. Calculation: 90 ÷ 28 = 3.21 pens

Therefore, 3 complete pens are needed for a 3-month supply, with a few days remaining on the fourth pen that would need to be started.

Important Administration Instructions

  • Forteo must be stored under refrigeration at 2°C to 8°C (36°F to 46°F) at all times 1
  • The pen should be recapped when not in use to protect from physical damage and light 1
  • Minimize time out of refrigerator; administer dose immediately after removal 1
  • Each pen can only be used for up to 28 days, after which it must be discarded even if solution remains 1
  • Patients should be instructed to take supplemental calcium and vitamin D if dietary intake is inadequate 1

Common Pitfalls to Avoid

  • Do not freeze Forteo or use if it has been frozen 1
  • Do not transfer contents of the pen to a syringe 1
  • Do not share pens between patients 1
  • Do not use beyond the 28-day period per pen, even if medication remains 1
  • Do not use after the expiration date printed on the pen 1

Remember that teriparatide is indicated for treatment of osteoporosis in postmenopausal women at high risk for fracture, men with primary or hypogonadal osteoporosis, and patients with glucocorticoid-induced osteoporosis 1.

References

Guideline

Osteoporosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.